Manufacturer of a wide range of products which include vigabatrin 500 mg tablet.
₹ 7820 / Box Get Latest Price
| Strength | 500 mg |
| Pack Size | 1*100 Tablets |
| Pack Size | 100 tablets |
| Pack Type | Bottle |
| Brand Name | LuciViga 500mg |
| Manufacturer | Lucius Pharmaceuticals, Laos |
| Usages | Treat seizures |
| Form | Tablet |
| Prescription/Non prescription | Prescription |
| Country of Origin | Laos |
| Composition | Vigabatrin |
| Shelf Life | 24 Months |
| Storage Condition | Store below 25 DegreeC |
Minimum order quantity: 10 Box
LuciViga 500mg contains Vigabatrin, an antiepileptic medication used primarily to treat seizures. It is especially beneficial for patients who do not respond to first-line therapies. Developed as a second-generation antiepileptic, LuciViga plays a critical role in managing epilepsy, particularly infantile spasms and refractory complex partial seizures.
Vigabatrin has a unique mechanism of action that distinguishes it from other anti-seizure medications, making it a valuable addition to seizure management protocols.
What is LuciViga 500mg?LuciViga 500mg is a prescription medicine that contains Vigabatrin, an antiepileptic agent. It is primarily used to treat:
Children's infantile spasms (ages two months to two years)
Refractory complex partial seizures in adults and children over 10 years who have not responded to other treatments
It is not a first-line drug but is recommended when other medications fail to provide adequate seizure control.
Vigabatrin works against epilepsy by permanently blocking the GABA transaminase (GABA-T) enzyme. This is how it operates:
In the central nervous system, GABA (gamma-aminobutyric acid) is the main inhibitory neurotransmitter.
Normally, the enzyme GABA-T breaks down GABA.
Vigabatrin blocks this enzyme, leading to increased levels of GABA in the brain.
Elevated GABA activity inhibits abnormal electrical activity, thereby reducing the frequency and intensity of seizures.
This mode of action is different from many other antiepileptic drugs, offering a novel pathway for controlling seizures.
LuciViga is indicated for:
Infantile Spasms (IS) – As monotherapy in children between 2 months and 2 years old.
Refractory Complex Partial Seizures (CPS) – As adjunctive therapy in adults and children (10 years and older) when other treatments have failed.
It should always be used under the supervision of a neurologist or epilepsy specialist due to the potential for serious side effects.
Adults (for CPS):
Starting dose: 500 mg twice daily
May be titrated up weekly by 500 mg/day
Maximum dose: 3,000 mg/day (1,500 mg twice daily)
Pediatrics (for Infantile Spasms): Dose is weight-based, typically 50-150 mg/kg/day divided into two doses
Administration Tips:
Can be taken with or without food
Tablets may be crushed and mixed with water or soft food for children or patients with difficulty swallowing
Always follow the prescribed regimen and do not stop abruptly
Oral solution: Often used for infants and small children who cannot swallow tablets
Powder for oral solution: Convenient for flexible pediatric dosing
Fatigue, drowsiness
Weight gain
Dizziness
Headache
Visual field defects (peripheral vision loss)
Permanent vision loss (boxed warning)
Behavioral changes (agitation, depression, psychosis)
Sedation and fatigue
Suicidal thoughts or behavior
Note: Regular eye exams are mandatory during therapy due to the risk of irreversible vision damage.
StorageStore below 25°C (77°F)
Keep in the original container, tightly closed
Protect from light and moisture
Keep out of reach of children
Tushar Ghanshyambhai Kalathiya (CEO)
Leaf Pharma
Ground Floor Plot No-19 Opp. Govindaji Hall, Dabholi Road, OPP. GOVINDAJI HALL, Surat - 395004, Gujarat, India